Identification and functional characterization of flgM, a gene encoding the anti-sigma 28 factor in Pseudomonas

A Frisk1, J Jyot, S K Arora

  • 1Department of Medicine, Division of Infectious Diseases, University of Florida, Gainesville, Florida 32610, USA.

Insights

The Pseudomonas aeruginosa flgM gene negatively regulates flagellin synthesis by inhibiting FliA activity. This finding reveals a unique control system for motility in this bacterium.

Area of Science:

  • Microbiology
  • Bacterial Physiology
  • Molecular Biology

Background:

  • Flagellar motility is crucial for bacterial pathogenesis and environmental adaptation.
  • The flgM gene product, FlgM, is known to regulate flagellar synthesis in some bacteria.
  • Pseudomonas aeruginosa is an opportunistic pathogen where motility plays a significant role.

Purpose of the Study:

  • To functionally characterize the flgM gene in Pseudomonas aeruginosa.
  • To elucidate the regulatory mechanism of flagellin synthesis controlled by FlgM.
  • To investigate the interaction between FlgM and the sigma factor FliA.

Main Methods:

  • Gene inactivation of flgM in P. aeruginosa.
  • Construction and analysis of transcriptional fusions (fliC-lacZ, flgM-lacZ).
  • Western blot analysis for flagellin detection.
  • Yeast two-hybrid system for protein interaction studies.
  • Primer extension to identify transcript start sites.

Main Results:

  • Inactivation of flgM led to increased fliC promoter activity and flagellin levels.
  • FlgM was shown to directly interact with the sigma-28 factor (FliA).
  • The flgM promoter exhibited both sigma-28-dependent and -independent transcription.
  • A novel regulatory system for flagellin synthesis was identified in P. aeruginosa.

Conclusions:

  • FlgM negatively regulates flagellin synthesis in P. aeruginosa by inhibiting FliA activity.
  • This regulatory mechanism differs from that in enteric bacteria and resembles systems in Vibrio cholerae.
  • The findings contribute to understanding bacterial motility regulation and potential therapeutic targets.